Metabolic health, obesity and 9-year incidence of peripheral arterial disease: The D.E.S.I.R. study

Atherosclerosis

Volumn 216, Issue 2, 2011, Pages 471-476

  Skilton, Michael R ^a   Chin Dusting, Jaye P F ^a   Dart, Anthony M ^a   Brazionis, Laima ^b   Lantieri, Olivier ^c   O'Dea, Kerin ^a,d   Balkau, Beverley ^a,e  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c IRSA   (France)

^d UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^e CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

Author keywords

Insulin resistance; Metabolic syndrome; Obesity; Overweight; Peripheral arterial disease

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; INCIDENCE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PANCREAS ISLET BETA CELL; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PULSE PRESSURE; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; ANKLE; ANKLE BRACHIAL INDEX; BODY WEIGHT; CHOLESTEROL, HDL; FEMALE; HUMANS; INSULIN; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; PERIPHERAL ARTERIAL DISEASE; PRINCIPAL COMPONENT ANALYSIS; TRIGLYCERIDES;

EID: 79957996068     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.02.032     Document Type: Article

References (23)

1. Wilson P.W., Bozeman S.R., Burton T.M., et al. Prediction of first events of coronary heart disease and stroke with consideration of adiposity. Circulation 2008, 118:124-130.
2. Karelis A.D., Faraj M., Bastard J.P., et al. The metabolically healthy but obese individual presents a favorable inflammation profile. J. Clin. Endocrinol. Metab. 2005, 90:4145-4150.
3. Fox C.S., Pencina M.J., Wilson P.W., et al. Lifetime risk of cardiovascular disease among individuals with and without diabetes stratified by obesity status in the Framingham heart study. Diabetes Care 2008, 31:1582-1584.
4. Resnick H.E., Lindsay R.S., McDermott M.M., et al. Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the strong heart study. Circulation 2004, 109:733-739.
5. Lahoz C., Vicente I., Laguna F., et al. Metabolic syndrome and asymptomatic peripheral artery disease in subjects over 60 years of age. Diabetes Care 2006, 29:148-150.
6. Planas A., Clara A., Pou J.M., et al. Relationship of obesity distribution and peripheral arterial occlusive disease in elderly men. Int. J. Obes. Relat. Metab. Disord. 2001, 25:1068-1070.
7. Selvin E., Erlinger T.P. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 2004, 110:738-743.
8. Balkau B., Eschwege E., Tichet J., Marre M. Proposed criteria for the diagnosis of diabetes: evidence from a French epidemiological study (D.E.S.I.R.). Diabetes Metab. 1997, 23:428-434.
9. Bernstein E.F., Fronek A. Current status of noninvasive tests in the diagnosis of peripheral arterial disease. Surg. Clin. North Am. 1982, 62:473-487.
10. Wallace T.M., Levy J.C., Matthews D.R. Use and abuse of HOMA modeling. Diabetes Care 2004, 27:1487-1495.
11. Grundy S.M., Cleeman J.I., Daniels S.R., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005, 112:2735-2752.
12. Ridker P.M., Stampfer M.J., Rifai N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 2001, 285:2481-2485.
13. Wattanakit K., Folsom A.R., Selvin E., et al. Risk factors for peripheral arterial disease incidence in persons with diabetes: the atherosclerosis risk in communities (ARIC) study. Atherosclerosis 2005, 180:389-397.
14. Katsilambros N.L., Tsapogas P.C., Arvanitis M.P., et al. Risk factors for lower extremity arterial disease in non-insulin-dependent diabetic persons. Diabetes Med 1996, 13:243-246.
15. Adler A.I., Stevens R.J., Neil A., et al. UKPDS 59: hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes. Diabetes Care 2002, 25:894-899.
16. Barter P.J., Caulfield M., Eriksson M., et al. Effects of torcetrapib in patients at high risk for coronary events. N. Engl. J. Med. 2007, 357:2109-2122.
17. Pradhan A.D., Shrivastava S., Cook N.R., et al. Symptomatic peripheral arterial disease in women: nontraditional biomarkers of elevated risk. Circulation 2008, 117:823-831.
18. Reaven G.M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988, 37:1595-1607.
19. Ziccardi P., Nappo F., Giugliano G., et al. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 2002, 105:804-809.
20. Skilton M.R., Sieveking D.P., Harmer J.A., et al. The effects of obesity and non-pharmacological weight loss on vascular and ventricular function and structure. Diabetes Obes. Metab. 2008, 10:874-884.
21. Conen D., Rexrode K.M., Creager M.A., Ridker P.M., Pradhan A.D. Metabolic syndrome, inflammation, and risk of symptomatic peripheral artery disease in women: a prospective study. Circulation 2009, 120:1041-1047.
22. Woollard K.J., Kling D., Kulkarni S., et al. Raised plasma soluble P-selectin in peripheral arterial occlusive disease enhances leukocyte adhesion. Circ. Res. 2006, 98:149-156.
23. Tapp R.J., Balkau B., Shaw J.E., et al. Association of glucose metabolism, smoking and cardiovascular risk factors with incident peripheral arterial disease: the DESIR study. Atherosclerosis 2007, 190:84-89.